# Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese Patients

> **NCT00517114** · NA · COMPLETED · sponsor: **Hospital Authority, Hong Kong** · enrollment: 200 (estimated)

## Conditions studied

- Gastroesophageal Reflux
- Laryngitis

## Interventions

- **DRUG:** Rabeprazole 20mg twice daily

## Key facts

- **NCT ID:** NCT00517114
- **Lead sponsor:** Hospital Authority, Hong Kong
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** 2008-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2013-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00517114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00517114, "Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00517114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*